# Active Surveillance for Low-risk Prostate Cancer - Evaluation of the Efficacy of Minimally Invasive Active Surveillance

> **NCT03956108** · NA · COMPLETED · sponsor: **Karolinska Institutet** · enrollment: 280 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

- **DIAGNOSTIC_TEST:** MRI+targeted biopsies+Stockholm3-test
- **DIAGNOSTIC_TEST:** PSA + systematic biopsies

## Key facts

- **NCT ID:** NCT03956108
- **Lead sponsor:** Karolinska Institutet
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-08-01
- **Primary completion:** 2019-12-12
- **Final completion:** 2020-03-01
- **Target enrollment:** 280 (ACTUAL)
- **Last updated:** 2020-09-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03956108

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03956108, "Active Surveillance for Low-risk Prostate Cancer - Evaluation of the Efficacy of Minimally Invasive Active Surveillance". Retrieved via AI Analytics 2026-07-09 from https://api.ai-analytics.org/clinical/NCT03956108. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*